Wolwo Pharma released its first-quarter performance, with a net profit attributable to the parent company of 74.3421 million yuan, a decrease of 3.71%
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, Wolwo Pharma released its first quarter report for 2025, with operating revenue of 228 million yuan, a year-on-year increase of 5.65%. The net profit attributable to shareholders of the listed company was 74.3421 million yuan, a year-on-year decrease of 3.71%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 73.6184 million yuan, a year-on-year increase of 1.48%. The basic earnings per share were 0.142 yuan
According to the Zhitong Finance APP, Wolwo Pharma (300357.SZ) released its first-quarter report for 2025, showing an operating income of 228 million yuan, a year-on-year increase of 5.65%. The net profit attributable to shareholders of the listed company was 74.3421 million yuan, a year-on-year decrease of 3.71%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 73.6184 million yuan, a year-on-year increase of 1.48%. The basic earnings per share were 0.142 yuan